Acetate

Generic Name: Acetate

Drug Type: Small Molecule

Chemical Formula: C_₂H_₃O_₂

CAS Number: 71-50-1

Unique Ingredient Identifier: 569DQM74SC

Clinical Trials

Abnormal Uterine Bleeding and Progestin-only Contraceptives

Completed

Conditions: Contraception

Interventions: Drug: Desogestrel 75 µg
Drug: Depot medroxy-progesterone acetate
Drug: Etonogestrel

First Posted Date: 2018-01-12

Last Posted Date: 2020-12-17

Lead Sponsor: Assiut University

Target Recruit Count: 390

Registration Number: NCT03398811

Locations: 🇪🇬
Women Health Hospital - Assiut university, Assiut, Egypt

Depot Medroxyprogesterone Acetate as Emergency Contraception

Early Phase 1

Completed

Conditions: Emergency Contraception
Contraception

Interventions: Drug: Depot-Medroxyprogestereone Acetate

First Posted Date: 2018-01-10

Last Posted Date: 2020-11-05

Lead Sponsor: University of Southern California

Target Recruit Count: 30

Registration Number: NCT03395756

Locations: 🇺🇸
University of Southern California Keck Medical Center, Los Angeles, California, United States

Metabolic Profile of Users of Hormonal and Non-hormonal Contraceptives

Completed

Conditions: Contraceptive Usage
Metabolic Syndrome
Body Weight Changes

Interventions: Drug: Combined Oral Contraceptive
Device: Intrauterine device
Drug: Progestin-only pills
Drug: Depot-Medroxyprogestereone Acetate

First Posted Date: 2017-12-26

Last Posted Date: 2017-12-26

Lead Sponsor: Federal University of São Paulo

Target Recruit Count: 489

Registration Number: NCT03383185

Locations: 🇧🇷
Federal University of Sao Paulo - Unifesp, São Paulo, SP, Brazil

A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe Pain

Phase 3

Terminated

Conditions: Endometriosis

Interventions: Drug: elagolix
Drug: estradiol/norethindrone acetate (E2/NETA)

First Posted Date: 2017-11-17

Last Posted Date: 2019-11-27

Lead Sponsor: AbbVie

Target Recruit Count: 11

Registration Number: NCT03343067

Locations: 🇺🇸
Quad Clinical Research, LLC /ID# 168294, Chicago, Illinois, United States
🇺🇸
Seattle Reproductive Medicine /ID# 171079, Seattle, Washington, United States
🇺🇸
Central Ohio Clinical Research /ID# 170750, Columbus, Ohio, United States

and more 34 locations

The Effect of Fluid Resuscitation With 0.9% Sodium Chloride Versus Balanced Crystalloid Solution on Renal Function of Sepsis Patients

Phase 3

Completed

Conditions: Sepsis
Septic Shock
Acute Kidney Injury

Interventions: Drug: Ringer's Acetate
Drug: Normal saline

First Posted Date: 2017-09-11

Last Posted Date: 2021-03-09

Lead Sponsor: Chulalongkorn University

Target Recruit Count: 116

Registration Number: NCT03277677

Locations: 🇹🇭
Chulalongkorn university, Bangkok, Thailand

Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients

Phase 2

Completed

Conditions: Breast Neoplasms

Interventions: Drug: Perjeta Injectable Product
Drug: Herceptin
Drug: Tamoxifen
Drug: Paclitaxel
Drug: Epirubicin
Drug: Cyclophosphamide
Drug: Anastrozole
Drug: Letrozole
Drug: Exemestane
Drug: Leuporelin acetate
Drug: Leuprorelin acetate
Drug: Goserelin
Diagnostic Test: Biopsy
Procedure: Surgery

First Posted Date: 2017-09-05

Last Posted Date: 2024-04-17

Lead Sponsor: Palleos Healthcare GmbH

Target Recruit Count: 257

Registration Number: NCT03272477

Locations: 🇩🇪
Evangelisches Krankenhaus Bethesda Mönchengladbach, Mönchengladbach, Germany

OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS

Phase 4

Completed

Conditions: PCOS

Interventions: Drug: Ethinyl Estradiol-cyprosterone acetate
Drug: Metformin Hydrochloride

First Posted Date: 2017-08-02

Last Posted Date: 2018-03-20

Lead Sponsor: S.C.B. Medical College and Hospital

Target Recruit Count: 101

Registration Number: NCT03236740

Locations: 🇮🇳
SCB Medical College, Cuttack, Orissa, India

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

Phase 3

Completed

Conditions: Endometriosis

Interventions: Drug: Estradiol/Norethindrone Acetate
Drug: Placebo for Elagolix
Drug: Elagolix
Drug: Placebo for E2/NETA

First Posted Date: 2017-07-11

Last Posted Date: 2024-12-20

Lead Sponsor: AbbVie

Target Recruit Count: 681

Registration Number: NCT03213457

Locations: 🇺🇸
Clinical Research Adv, Inc. /ID# 149257, Puyallup, Washington, United States
🇺🇸
Tidewater Clinical Research /ID# 145397, Virginia Beach, Virginia, United States
🇺🇸
Atlanta Women's Research Inst /ID# 145543, Atlanta, Georgia, United States

and more 194 locations

Hemodynamic Effects of Cold Versus Warm Fluid Bolus

Not Applicable

Completed

Conditions: Temperature Change, Body
Hypovolemia

Interventions: Drug: Ringer's Acetate (warm)
Drug: Ringer's Acetate (cold)

First Posted Date: 2017-07-06

Last Posted Date: 2017-07-06

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 21

Registration Number: NCT03209271

Locations: 🇸🇪
Karolinska Institutet Södersjukhuset, Stockholm, Sweden

SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

Phase 3

Completed

Conditions: Endometriosis Related Pain

Interventions: Drug: Relugolix
Drug: Estradiol/norethindrone acetate
Drug: Relugolix placebo
Drug: Estradiol/norethindrone acetate placebo

First Posted Date: 2017-07-02

Last Posted Date: 2021-06-28

Lead Sponsor: Myovant Sciences GmbH

Target Recruit Count: 638

Registration Number: NCT03204318

Locations: 🇺🇸
Miami, Miami, Florida, United States
🇺🇸
Seattle, Seattle, Washington, United States
🇺🇸
San Diego, San Diego, California, United States

and more 98 locations

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy